FDA approves Genentech’s Vabysmo Prefilled Syringe (PFS) for three leading causes of vision loss
Vabysmo PFS is reportedly the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
age-related macular degeneration
Age-related macular degeneration market across 7MM set to reach $27.5 bn in 2031: GlobalData
Therapies with longer treatment intervals are a dominant trend in the AMD pipeline
Boehringer Ingelheim and CDR-Life to develop Antibody Fragment-based Therapeutics for Geographic…
The collaboration with CDR-Life is the second strategic partnership within a year for Boehringer Ingelheim in retinal diseases,…